[1]
|
The Human Microbiome Project Consortium (2012) Structure, Function and Diversity of the Healthy Human Microbiome. Nature, 486, 207-214.
https://doi.org/10.1038/nature11234
|
[2]
|
Guarner, F. and Malagelada, J.R. (2003) Gut Flora in Health and Disease. The Lancet, 361, 512-519. https://doi.org/10.1016/S0140-6736(03)12489-0
|
[3]
|
Morrison, D.J. and Preston, T. (2016) Formation of Short Chain Fatty Acids by the Gut Microbiota and Their Impact on Human Metabolism. Gut Microbes, 7, 189-200. https://doi.org/10.1080/19490976.2015.1134082
|
[4]
|
Ríos-Covián, D., Ruas-Madiedo, P., Margolles, A., Gueimonde, M., de Los Reyes-Gavilán, C.G. and Salazar, N. (2016) Intestinal Short Chain Fatty Acids and Their Link with Diet and Human Health. Frontiers in Microbiology, 7, Article 185.
https://doi.org/10.3389/fmicb.2016.00185
|
[5]
|
Rooks, M.G. and Garrett, W.S. (2016) Gut Microbiota, Metabolites and Host Immunity. Nature Reviews Immunology, 16, 341-352.
https://doi.org/10.1038/nri.2016.42
|
[6]
|
Bäckhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A. and Gordon, J.I. (2005) Host-Bacterial Mutualism in the Human Intestine. Science, 307, 1915-1920.
https://doi.org/10.1126/science.1104816
|
[7]
|
Garrett, W.S. (2019) The Gut Microbiota and Colon Cancer. Science, 364, 1133-1135. https://doi.org/10.1126/science.aaw2367
|
[8]
|
Mentella, M.C., Scaldaferri, F., Pizzoferrato, M., Gasbarrini, A. and Miggiano, G.A.D. (2020) Nutrition, IBD and Gut Microbiota: A Review. Nutrients, 12, Article 944. https://doi.org/10.3390/nu12040944
|
[9]
|
Cox, A.J., West, N.P. and Cripps, A.W. (2015) Obesity, Inflammation, and the Gut Microbiota. The Lancet Diabetes & Endocrinology, 3, 207-215.
https://doi.org/10.1016/S2213-8587(14)70134-2
|
[10]
|
Witkowski, M., Weeks, T.L. and Hazen, S.L. (2020) Gut Microbiota and Cardiovascular Disease. Circulation Research, 127, 553-570.
https://doi.org/10.1161/CIRCRESAHA.120.316242
|
[11]
|
Miller, T.L. and Wolin, M.J. (1996) Pathways of Acetate, Propionate, and Butyrate Formation by the Human Fecal Microbial Flora. Applied and Environmental Microbiology, 62, 1589-1592. https://doi.org/10.1128/aem.62.5.1589-1592.1996
|
[12]
|
Macfarlane, S. and Macfarlane, G.T. (2003) Regulation of Short-Chain Fatty Acid Production. Proceedings of the Nutrition Society, 62, 67-72.
https://doi.org/10.1079/PNS2002207
|
[13]
|
He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., Zhao, Y., Bai, L., Hao, X., Li, X., Zhang, S. and Zhu, L. (2020) Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. International Journal of Molecular Sciences, 21, Article 6356.
https://doi.org/10.3390/ijms21176356
|
[14]
|
Stumpff, F. (2018) A Look at the Smelly Side of Physiology: Transport of Short Chain Fatty Acids. Pflügers Archiv, 470, 571-598.
https://doi.org/10.1007/s00424-017-2105-9
|
[15]
|
Schönfeld, P. and Wojtczak, L. (2016) Short- and Medium-Chain Fatty Acids in Energy Metabolism: The Cellular Perspective. Journal of Lipid Research, 57, 943-954. https://doi.org/10.1194/jlr.R067629
|
[16]
|
Cummings, J.H., Pomare, E.W., Branch, W.J., Naylor, C.P. and Macfarlane, G.T. (1987) Short Chain Fatty Acids in Human Large Intestine, Portal, Hepatic and Venous Blood. Gut, 28, 1221-1227. https://doi.org/10.1136/gut.28.10.1221
|
[17]
|
Koh, A., De Vadder, F., Kovatcheva-Datchary, P. and Bäckhed, F. (2016) From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell, 165, 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
|
[18]
|
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A.N., Mackay, C.R. and Macia, L. (2014) The Role of Short-Chain Fatty Acids in Health and Disease. Advances in Immunology, 121, 91-119. https://doi.org/10.1016/B978-0-12-800100-4.00003-9
|
[19]
|
Michaudel, C. and Sokol, H. (2020) The Gut Microbiota at the Service of Immunometabolism. Cell Metabolism, 32, 514-523.
https://doi.org/10.1016/j.cmet.2020.09.004
|
[20]
|
Venkatakrishnan, A.J., Deupi, X., Lebon, G., Tate, C.G., Schertler, G.F. and Babu, M.M. (2013) Molecular Signatures of G-Protein-Coupled Receptors. Nature, 494, 185-194. https://doi.org/10.1038/nature11896
|
[21]
|
Wu, F., Song, G., de Graaf, C. and Stevens, R.C. (2017) Structure and Function of Peptide-Binding G Protein-Coupled Receptors. Journal of Molecular Biology, 429, 2726-2745. https://doi.org/10.1016/j.jmb.2017.06.022
|
[22]
|
Tan, J.K., McKenzie, C., Mariño, E., Macia, L. and Mackay, C.R. (2017) Metabolite-Sensing G Protein-Coupled Receptors-Facilitators of Diet-Related Immune Regulation. Annual Review of Immunology, 35, 371-402.
https://doi.org/10.1146/annurev-immunol-051116-052235
|
[23]
|
Li, L., Ma, L. and Fu, P. (2017) Gut Microbiota-Derived Short-Chain Fatty Acids and Kidney Diseases. Drug Design, Development and Therapy, 11, 3531-3542.
https://doi.org/10.2147/DDDT.S150825
|
[24]
|
Fellows, R., Denizot, J., Stellato, C., Cuomo, A., Jain, P., Stoyanova, E., Balázsi, S., Hajnády, Z., Liebert, A., Kazakevych, J., Blackburn, H., Corrêa, R.O., Fachi, J.L., Sato, F.T., Ribeiro, W.R., Ferreira, C.M., Perée, H., Spagnuolo, M., Mattiuz, R., Matolcsi, C., Guedes, J., Clark, J., Veldhoen, M., Bonaldi, T., Vinolo, M.A.R. and Varga-Weisz, P. (2018) Microbiota Derived Short Chain Fatty Acids Promote Histone Crotonylation in the Colon through Histone Deacetylases. Nature Communications, 9, Article No. 105. https://doi.org/10.1038/s41467-017-02651-5
|
[25]
|
Oldendorf, W.H. (1973) Carrier-Mediated Blood-Brain Barrier Transport of Short-Chain Monocarboxylic Organic Acids. American Physiological Society, 224, 1450-1453. https://doi.org/10.1152/ajplegacy.1973.224.6.1450
|
[26]
|
Corrêa-Oliveira, R., Fachi, J.L., Vieira, A., Sato, F.T. and Vinolo, M.A. (2016) Regulation of Immune Cell Function by Short-Chain Fatty Acids. Clinical & Translational Immunology, 5, e73. https://doi.org/10.1038/cti.2016.17
|
[27]
|
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G.I., Eilers, E., Bader, V., Haase, S., Kaisler, J., David, C., Schneider, R., Troisi, R., Zent, D., Hegelmaier, T., Dokalis, N., Gerstein, S., Del Mare-Roumani, S., Amidror, S., Staszewski, O., Poschmann, G., Stühler, K., Hirche, F., Balogh, A., Kempa, S., Träger, P., Zaiss, M.M., Holm, J.B., Massa, M.G., Nielsen, H.B., Faissner, A., Lukas, C., Gatermann, S.G., Scholz, M., Przuntek, H., Prinz, M., Forslund, S.K., Winklhofer, K.F., Müller, D.N., Linker, R.A., Gold, R. and Haghikia, A. (2020) Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism. Cell, 180, 1067-1080.e1016. https://doi.org/10.1016/j.cell.2020.02.035
|
[28]
|
Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.H., May, C., Wilck, N., Balogh, A., Ostermann, A.I., Schebb, N.H., Akkad, D.A., Grohme, D.A., Kleinewietfeld, M., Kempa, S., Thöne, J., Demir, S., Müller, D.N., Gold, R. and Linker, R.A. (2015) Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity, 43, 817-829. https://doi.org/10.1016/j.immuni.2015.09.007
|
[29]
|
Mizuno, M., Noto, D., Kaga, N., Chiba, A. and Miyake, S. (2017) The Dual Role of Short Fatty Acid Chains in the Pathogenesis of Autoimmune Disease Models. PLOS ONE, 12, e0173032. https://doi.org/10.1371/journal.pone.0173032
|
[30]
|
Chitrala, K.N., Guan, H., Singh, N.P., Busbee, B., Gandy, A., Mehrpouya-Bahrami, P., Ganewatta, M.S., Tang, C., Chatterjee, S., Nagarkatti, P. and Nagarkatti, M. (2017) CD44 Deletion Leading to Attenuation of Experimental Autoimmune Encephalomyelitis Results from Alterations in Gut Microbiome in Mice. European Journal of Immunology, 47, 1188-1199. https://doi.org/10.1002/eji.201646792
|
[31]
|
Chen, T., Noto, D., Hoshino, Y., Mizuno, M. and Miyake, S. (2019) Butyrate Suppresses Demyelination and Enhances Remyelination. Journal of Neuroinflammation, 16, Article No. 165. https://doi.org/10.1186/s12974-019-1552-y
|
[32]
|
Hardoff, R., Sula, M., Tamir, A., Soil, A., Front, A., Badarna, S., Honigman, S. and Giladi, N. (2001) Gastric Emptying Time and Gastric Motility in Patients with Parkinson’s Disease. Movement Disorders, 16, 1041-1047.
https://doi.org/10.1002/mds.1203
|
[33]
|
Cersosimo, M.G., Raina, G.B., Pecci, C., Pellene, A., Calandra, C.R., Gutiérrez, C., Micheli, F.E. and Benarroch, E.E. (2013) Gastrointestinal Manifestations in Parkinson’s Disease: Prevalence and Occurrence before Motor Symptoms. Journal of Neurology, 260, 1332-1338. https://doi.org/10.1007/s00415-012-6801-2
|
[34]
|
Braak, H., de Vos, R.A., Bohl, J. and Del Tredici, K. (2006) Gastric Alpha-Synuclein Immunoreactive Inclusions in Meissner’s and Auerbach’s Plexuses in Cases Staged for Parkinson’s Disease-Related Brain Pathology. Neuroscience Letters, 396, 67-72.
https://doi.org/10.1016/j.neulet.2005.11.012
|
[35]
|
Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E. and Ikuta, F. (1988) Parkinson’s Disease: The Presence of Lewy Bodies in Auerbach’s and Meissner’s Plexuses. Acta Neuropathologica, 76, 217-221. https://doi.org/10.1007/BF00687767
|
[36]
|
Barichella, M., Severgnini, M., Cilia, R., Cassani, E., Bolliri, C., Caronni, S., Ferri, V., Cancello, R., Ceccarani, C., Faierman, S., Pinelli, G., De Bellis, G., Zecca, L., Cereda, E., Consolandi, C. and Pezzoli, G. (2019) Unraveling Gut Microbiota in Parkinson’s Disease and Atypical Parkinsonism. Movement Disorders, 34, 396-405.
https://doi.org/10.1002/mds.27581
|
[37]
|
Aho, V.T.E., Pereira, P.A.B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P. and Scheperjans, F. (2019) Gut Microbiota in Parkinson’s Disease: Temporal Stability and Relations to Disease Progression. eBioMedicine, 44, 691-707.
https://doi.org/10.1016/j.ebiom.2019.05.064
|
[38]
|
Unger, M.M., Spiegel, J., Dillmann, K.U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A. and Schäfer, K.H. (2016) Short Chain Fatty Acids and Gut Microbiota Differ between Patients with Parkinson’s Disease and Age-Matched Controls. Parkinsonism & Related Disorders, 32, 66-72.
https://doi.org/10.1016/j.parkreldis.2016.08.019
|
[39]
|
Liu, J., Wang, F., Liu, S., Du, J., Hu, X., Xiong, J., Fang, R., Chen, W. and Sun, J. (2017) Sodium Butyrate Exerts Protective Effect against Parkinson’s Disease in Mice via Stimulation of Glucagon Like Peptide-1. Journal of the Neurological Sciences, 381, 176-181. https://doi.org/10.1016/j.jns.2017.08.3235
|
[40]
|
Li, X., Fan, X., Yuan, X., Pang, L., Hu, S., Wang, Y., Huang, X. and Song, X. (2021) The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia. Frontiers in Psychiatry, 12, Article ID: 724664.
https://doi.org/10.3389/fpsyt.2021.724664
|
[41]
|
Malhi, G.S. and Mann, J.J. (2018) Depression. The Lancet, 392, 2299-2312.
https://doi.org/10.1016/S0140-6736(18)31948-2
|
[42]
|
Harmer, C.J., Duman, R.S. and Cowen, P.J. (2017) How Do Antidepressants Work? New Perspectives for Refining Future Treatment Approaches. The Lancet Psychiatry, 4, 409-418. https://doi.org/10.1016/S2215-0366(17)30015-9
|
[43]
|
Cruz-Pereira, J.S., Rea, K., Nolan, Y.M., O’Leary, O.F., Dinan, T.G. and Cryan, J.F. (2020) Depression’s Unholy Trinity: Dysregulated Stress, Immunity, and the Microbiome. Annual Review of Psychology, 71, 49-78.
https://doi.org/10.1146/annurev-psych-122216-011613
|
[44]
|
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., Zhang, X., Yang, D., Yang, Y., Meng, H., Li, W., Melgiri, N.D., Licinio, J., Wei, H. and Xie, P. (2016) Gut Microbiome Remodeling Induces Depressive-Like Behaviors through a Pathway Mediated by the Host’s Metabolism. Molecular Psychiatry, 21, 786-796. https://doi.org/10.1038/mp.2016.44
|
[45]
|
Wu, M., Tian, T., Mao, Q., Zou, T., Zhou, C.J., Xie, J. and Chen, J.J. (2020) Associations between Disordered Gut Microbiota and Changes of Neurotransmitters and Short-Chain Fatty Acids in Depressed Mice. Translational Psychiatry, 10, Article No. 350. https://doi.org/10.1038/s41398-020-01038-3
|
[46]
|
Müller, B., Rasmusson, A.J., Just, D., Jayarathna, S., Moazzami, A., Novicic, Z.K. and Cunningham, J.L. (2021) Fecal Short-Chain Fatty Acid Ratios as Related to Gastrointestinal and Depressive Symptoms in Young Adults. Psychosomatic Medicine, 83, 693-699. https://doi.org/10.1097/PSY.0000000000000965
|
[47]
|
Yan, Q., Gu, Y., Li, X., Yang, W., Jia, L., Chen, C., Han, X., Huang, Y., Zhao, L., Li, P., Fang, Z., Zhou, J., Guan, X., Ding, Y., Wang, S., Khan, M., Xin, Y., Li, S. and Ma, Y. (2017) Alterations of the Gut Microbiome in Hypertension. Frontiers in Cellular and Infection Microbiology, 7, Article 381.
https://doi.org/10.3389/fcimb.2017.00381
|
[48]
|
Sun, S., Lulla, A., Sioda, M., Winglee, K., Wu, M.C., Jacobs Jr., D.R., Shikany, J.M., Lloyd-Jones, D.M., Launer, L.J., Fodor, A.A. and Meyer, K.A. (2019) Gut Microbiota Composition and Blood Pressure. Hypertension, 73, 998-1006.
https://doi.org/10.1161/HYPERTENSIONAHA.118.12109
|
[49]
|
Li, J., Zhao, F., Wang, Y., Chen, J., Tao, J., Tian, G., Wu, S., Liu, W., Cui, Q., Geng, B., Zhang, W., Weldon, R., Auguste, K., Yang, L., Liu, X., Chen, L., Yang, X., Zhu, B. and Cai, J. (2017) Gut Microbiota Dysbiosis Contributes to the Development of Hypertension. Microbiome, 5, Article No. 14.
https://doi.org/10.1186/s40168-016-0222-x
|
[50]
|
Kim, S., Goel, R., Kumar, A., Qi, Y., Lobaton, G., Hosaka, K., Mohammed, M., Handberg, E.M., Richards, E.M., Pepine, C.J. and Raizada, M.K. (2018) Imbalance of Gut Microbiome and Intestinal Epithelial Barrier Dysfunction in Patients with High Blood Pressure. Clinical Science (Lond), 132, 701-718.
https://doi.org/10.1042/CS20180087
|
[51]
|
Bartolomaeus, H., Balogh, A., Yakoub, M., Homann, S., Markó, L., Höges, S., Tsvetkov, D., Krannich, A., Wundersitz, S., Avery, E.G., Haase, N., Kräker, K., Hering, L., Maase, M., Kusche-Vihrog, K., Grandoch, M., Fielitz, J., Kempa, S., Gollasch, M., Zhumadilov, Z., Kozhakhmetov, S., Kushugulova, A., Eckardt, K.U., Dechend, R., Rump, L.C., Forslund, S.K., Müller, D.N., Stegbauer, J. and Wilck, N. (2019) Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage. Circulation, 139, 1407-1421.
https://doi.org/10.1161/CIRCULATIONAHA.118.036652
|
[52]
|
Liu, W., Luo, X., Tang, J., Mo, Q., Zhong, H., Zhang, H. and Feng, F. (2021) A Bridge for Short-Chain Fatty Acids to Affect Inflammatory Bowel Disease, Type 1 Diabetes, and Non-Alcoholic Fatty Liver Disease Positively: By Changing Gut Barrier. European Journal of Nutrition, 60, 2317-2330.
https://doi.org/10.1007/s00394-020-02431-w
|
[53]
|
Vinolo, M.A., Rodrigues, H.G., Hatanaka, E., Sato, F.T., Sampaio, S.C. and Curi, R. (2011) Suppressive Effect of Short-Chain Fatty Acids on Production of Proinflammatory Mediators by Neutrophils. The Journal of Nutritional Biochemistry, 22, 849-855. https://doi.org/10.1016/j.jnutbio.2010.07.009
|
[54]
|
Pluznick, J. (2014) A Novel SCFA Receptor, the Microbiota, and Blood Pressure Regulation. Gut Microbes, 5, 202-207. https://doi.org/10.4161/gmic.27492
|
[55]
|
Natarajan, N., Hori, D., Flavahan, S., Steppan, J., Flavahan, N.A., Berkowitz, D.E. and Pluznick, J.L. (2016) Microbial Short Chain Fatty Acid Metabolites Lower Blood Pressure via Endothelial G Protein-Coupled Receptor 41. Physiological Genomics, 48, 826-834. https://doi.org/10.1152/physiolgenomics.00089.2016
|
[56]
|
Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey Jr., D.E., Colvin, M.M., Drazner, M.H., Filippatos, G.S., Fonarow, G.C., Givertz, M.M., Hollenberg, S.M., Lindenfeld, J., Masoudi, F.A., McBride, P.E., Peterson, P.N., Stevenson, L.W. and Westlake, C. (2017) 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation, 136, e137-e161.
https://doi.org/10.1161/CIR.0000000000000509
|
[57]
|
Tang, W.H.W., Li, D.Y. and Hazen, S.L. (2019) Dietary Metabolism, the Gut Microbiome, and Heart Failure. Nature Reviews Cardiology, 16, 137-154.
https://doi.org/10.1038/s41569-018-0108-7
|
[58]
|
Munger, M.A., Johnson, B., Amber, I.J., Callahan, K.S. and Gilbert, E.M. (1996) Circulating Concentrations of Proinflammatory Cytokines in Mild or Moderate Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy. American Journal of Cardiology, 77, 723-727.
https://doi.org/10.1016/S0002-9149(97)89206-5
|
[59]
|
Sandek, A., Bauditz, J., Swidsinski, A., Buhner, S., Weber-Eibel, J., von Haehling, S., Schroedl, W., Karhausen, T., Doehner, W., Rauchhaus, M., Poole-Wilson, P., Volk, H.D., Lochs, H. and Anker, S.D. (2007) Altered Intestinal Function in Patients with Chronic Heart Failure. Journal of the American College of Cardiology, 50, 1561-1569. https://doi.org/10.1016/j.jacc.2007.07.016
|
[60]
|
Carley, A.N., Maurya, S.K., Fasano, M., Wang, Y., Selzman, C.H., Drakos, S.G. and Lewandowski, E.D. (2021) Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart. Circulation, 143, 1797-1808.
https://doi.org/10.1161/CIRCULATIONAHA.120.052671
|
[61]
|
Zuo, K., Li, J., Li, K., Hu, C., Gao, Y., Chen, M., Hu, R., Liu, Y., Chi, H., Wang, H., Qin, Y., Liu, X., Li, S., Cai, J., Zhong, J. and Yang, X. (2019) Disordered Gut Microbiota and Alterations in Metabolic Patterns Are Associated with Atrial Fibrillation. Gigascience, 8, giz058. https://doi.org/10.1093/gigascience/giz058
|
[62]
|
Zuo, K., Li, J., Wang, P., Liu, Y., Liu, Z., Yin, X., Liu, X. and Yang, X. (2019) Duration of Persistent Atrial Fibrillation Is Associated with Alterations in Human Gut Microbiota and Metabolic Phenotypes. mSystems, 4, e00422-19.
https://doi.org/10.1128/mSystems.00422-19
|
[63]
|
Zuo, K., Yin, X., Li, K., Zhang, J., Wang, P., Jiao, J., Liu, Z., Liu, X., Liu, J., Li, J. and Yang, X. (2020) Different Types of Atrial Fibrillation Share Patterns of Gut Microbiota Dysbiosis. mSphere, 5, e00071-20. https://doi.org/10.1128/mSphere.00071-20
|
[64]
|
Nattel, S., Heijman, J., Zhou, L. and Dobrev, D. (2020) Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective. Circulation Research, 127, 51-72. https://doi.org/10.1161/CIRCRESAHA.120.316363
|
[65]
|
Van Wagoner, D.R. and Chung, M.K. (2018) Inflammation, Inflammasome Activation, and Atrial Fibrillation. Circulation, 138, 2243-2246.
https://doi.org/10.1161/CIRCULATIONAHA.118.036143
|
[66]
|
Feng, Y., Wang, Y., Wang, P., Huang, Y. and Wang, F. (2018) Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy. Cellular Physiology and Biochemistry, 49, 190-205. https://doi.org/10.1159/000492853
|
[67]
|
Xu, M., Jiang, Z., Wang, C., Li, N., Bo, L., Zha, Y., Bian, J., Zhang, Y. and Deng, X. (2019) Acetate Attenuates Inflammasome Activation through GPR43-Mediated Ca2+-Dependent NLRP3 Ubiquitination. Experimental & Molecular Medicine, 51, 1-13. https://doi.org/10.1038/s12276-019-0276-5
|
[68]
|
Zhou, M., Li, D., Xie, K., Xu, L., Kong, B., Wang, X., Tang, Y., Liu, Y. and Huang, H. (2021) The Short-Chain Fatty Acid Propionate Improved Ventricular Electrical Remodeling in a Rat Model with Myocardial Infarction. Food & Function, 12, 12580-12593. https://doi.org/10.1039/D1FO02040D
|
[69]
|
Budden, K.F., Gellatly, S.L., Wood, D.L., Cooper, M.A., Morrison, M., Hugenholtz, P. and Hansbro, P.M. (2017) Emerging Pathogenic Links between Microbiota and the Gut-Lung Axis. Nature Reviews Microbiology, 15, 55-63.
https://doi.org/10.1038/nrmicro.2016.142
|
[70]
|
Liu, Q., Tian, X., Maruyama, D., Arjomandi, M. and Prakash, A. (2021) Lung Immune Tone via Gut-Lung Axis: Gut-Derived LPS and Short-Chain Fatty Acids’ Immunometabolic Regulation of Lung IL-1β, FFAR2, and FFAR3 Expression. American Journal of Physiology-Lung Cellular and Molecular Physiology, 321, L65-L78. https://doi.org/10.1152/ajplung.00421.2020
|
[71]
|
Marsland, B.J., Trompette, A. and Gollwitzer, E.S. (2015) The Gut-Lung Axis in Respiratory Disease. Annals of the American Thoracic Society, 12, S150-S156. https://doi.org/10.1513/AnnalsATS.201503-133AW
|
[72]
|
Ichinohe, T., Pang, I.K., Kumamoto, Y., Peaper, D.R., Ho, J.H., Murray, T.S. and Iwasaki, A. (2011) Microbiota Regulates Immune Defense against Respiratory Tract Influenza A Virus Infection. Proceedings of the National Academy of Sciences of the United States of America, 108, 5354-5359.
https://doi.org/10.1073/pnas.1019378108
|
[73]
|
Fagundes, C.T., Amaral, F.A., Vieira, A.T., Soares, A.C., Pinho, V., Nicoli, J.R., Vieira, L.Q., Teixeira, M.M. and Souza, D.G. (2012) Transient TLR Activation Restores Inflammatory Response and Ability to Control Pulmonary Bacterial Infection in Germfree Mice. The Journal of Immunology, 188, 1411-1420.
https://doi.org/10.4049/jimmunol.1101682
|
[74]
|
Dang, A.T. and Marsland, B.J. (2019) Microbes, Metabolites, and the Gut-Lung Axis. Mucosal Immunology, 12, 843-850.
https://doi.org/10.1038/s41385-019-0160-6
|
[75]
|
Roe, A.J., O’Byrne, C., McLaggan, D. and Booth, I.R. (2002) Inhibition of Escherichia coli Growth by Acetic Acid: A Problem with Methionine Biosynthesis and Homocysteine Toxicity. Microbiology (Reading), 148, 2215-2222.
https://doi.org/10.1099/00221287-148-7-2215
|
[76]
|
Roe, A.J., McLaggan, D., Davidson, I., O’Byrne, C. and Booth, I.R. (1998) Perturbation of Anion Balance during Inhibition of Growth of Escherichia coli by Weak Acids. Journal of Bacteriology, 180, 767-772.
https://doi.org/10.1128/JB.180.4.767-772.1998
|
[77]
|
Lawhon, S.D., Maurer, R., Suyemoto, M. and Altier, C. (2002) Intestinal Short-Chain Fatty Acids Alter Salmonella typhimurium Invasion Gene Expression and Virulence through BarA/SirA. Molecular Microbiology, 46, 1451-1464.
https://doi.org/10.1046/j.1365-2958.2002.03268.x
|
[78]
|
Ang, Z., Xiong, D., Wu, M. and Ding, J.L. (2018) FFAR2-FFAR3 Receptor Heteromerization Modulates Short-Chain Fatty Acid Sensing. The FASEB Journal, 32, 289-303. https://doi.org/10.1096/fj.201700252RR
|
[79]
|
Sunkara, L.T., Jiang, W. and Zhang, G. (2012) Modulation of Antimicrobial Host Defense Peptide Gene Expression by Free Fatty Acids. PLOS ONE, 7, e49558.
https://doi.org/10.1371/journal.pone.0049558
|
[80]
|
Cait, A., Hughes, M.R., Antignano, F., Cait, J., Dimitriu, P.A., Maas, K.R., Reynolds, L.A., Hacker, L., Mohr, J., Finlay, B.B., Zaph, C., McNagny, K.M. and Mohn, W.W. (2018) Microbiome-Driven Allergic Lung Inflammation Is Ameliorated by Short-Chain Fatty Acids. Mucosal Immunology, 11, 785-795.
https://doi.org/10.1038/mi.2017.75
|
[81]
|
Roduit, C., Frei, R., Ferstl, R., Loeliger, S., Westermann, P., Rhyner, C., Schiavi, E., Barcik, W., Rodriguez-Perez, N., Wawrzyniak, M., Chassard, C., Lacroix, C., Schmausser-Hechfellner, E., Depner, M., von Mutius, E., Braun-Fahrländer, C., Karvonen, A.M., Kirjavainen, P.V., Pekkanen, J., Dalphin, J.C., Riedler, J., Akdis, C., Lauener, R. and O’Mahony, L. (2019) High Levels of Butyrate and Propionate in Early Life Are Associated with Protection Against Atopy. Allergy, 74, 799-809.
https://doi.org/10.1111/all.13660
|
[82]
|
Theiler, A., Bärnthaler, T., Platzer, W., Richtig, G., Peinhaupt, M., Rittchen, S., Kargl, J., Ulven, T., Marsh, L.M., Marsche, G., Schuligoi, R., Sturm, E.M. and Heinemann, A. (2019) Butyrate Ameliorates Allergic Airway Inflammation by Limiting Eosinophil Trafficking and Survival. The Journal of Allergy and Clinical Immunology, 144, 764-776. https://doi.org/10.1016/j.jaci.2019.05.002
|
[83]
|
Folkerts, J., Redegeld, F., Folkerts, G., Blokhuis, B., van den Berg, M.P.M., de Bruijn, M.J.W., van, I.W.F.J., Junt, T., Tam, S.Y., Galli, S.J., Hendriks, R.W., Stadhouders, R. and Maurer, M. (2020) Butyrate Inhibits Human Mast Cell Activation via Epigenetic Regulation of FcεRI-Mediated Signaling. Allergy, 75, 1966-1978.
https://doi.org/10.1111/all.14254
|
[84]
|
Wypych, T.P., Marzi, R., Wu, G.F., Lanzavecchia, A. and Sallusto, F. (2018) Role of B Cells in TH Cell Responses in a Mouse Model of Asthma. The Journal of Allergy and Clinical Immunology, 141, 1395-1410.
https://doi.org/10.1016/j.jaci.2017.09.001
|
[85]
|
Sanchez, H.N., Moroney, J.B., Gan, H., Shen, T., Im, J.L., Li, T., Taylor, J.R., Zan, H. and Casali, P. (2020) B Cell-Intrinsic Epigenetic Modulation of Antibody Responses by Dietary Fiber-Derived Short-Chain Fatty Acids. Nature Communications, 11, Article No. 60. https://doi.org/10.1038/s41467-019-13603-6
|
[86]
|
Hu, Y., Feng, Y., Wu, J., Liu, F., Zhang, Z., Hao, Y., Liang, S., Li, B., Li, J., Lv, N., Xu, Y., Zhu, B. and Sun, Z. (2019) The Gut Microbiome Signatures Discriminate Healthy from Pulmonary Tuberculosis Patients. Frontiers in Cellular and Infection Microbiology, 9, Article 90. https://doi.org/10.3389/fcimb.2019.00090
|
[87]
|
Lee, H.Y., Nam, S., Kim, M.J., Kim, S.J., Back, S.H. and Yoo, H.J. (2021) Butyrate Prevents TGF-β1-Induced Alveolar Myofibroblast Differentiation and Modulates Energy Metabolism. Metabolites, 11, Article 258.
https://doi.org/10.3390/metabo11050258
|
[88]
|
Gülden, E., Ihira, M., Ohashi, A., Reinbeck, A.L., Freudenberg, M.A., Kolb, H. and Burkart, V. (2013) Toll-Like Receptor 4 Deficiency Accelerates the Development of Insulin-Deficient Diabetes in Non-Obese Diabetic Mice. PLOS ONE, 8, e75385.
https://doi.org/10.1371/journal.pone.0075385
|
[89]
|
Regard, J.B., Kataoka, H., Cano, D.A., Camerer, E., Yin, L., Zheng, Y.W., Scanlan, T.S., Hebrok, M. and Coughlin, S.R. (2007) Probing Cell Type-Specific Functions of Gi in Vivo Identifies GPCR Regulators of Insulin Secretion. Journal of Clinical Investigation, 117, 4034-4043. https://doi.org/10.1172/JCI32994
|
[90]
|
Stumvoll, M., Goldstein, B.J. and van Haeften, T.W. (2005) Type 2 Diabetes: Principles of Pathogenesis and Therapy. The Lancet, 365, 1333-1346.
https://doi.org/10.1016/S0140-6736(05)61032-X
|
[91]
|
Hong, Y.H., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C., Choi, K.C., Feng, D.D., Chen, C., Lee, H.G., Katoh, K., Roh, S.G. and Sasaki, S. (2005) Acetate and Propionate Short Chain Fatty Acids Stimulate Adipogenesis via GPCR43. Endocrinology, 146, 5092-5099. https://doi.org/10.1210/en.2005-0545
|
[92]
|
Tolhurst, G., Heffron, H., Lam, Y.S., Parker, H.E., Habib, A.M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F. and Gribble, F.M. (2012) Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2. Diabetes, 61, 364-371. https://doi.org/10.2337/db11-1019
|
[93]
|
Reimer, R.A., Darimont, C., Gremlich, S., Nicolas-Métral, V., Rüegg, U.T. and Macé, K. (2001) A Human Cellular Model for Studying the Regulation of Glucagon-Like Peptide-1 Secretion. Endocrinology, 142, 4522-4528.
https://doi.org/10.1210/endo.142.10.8415
|
[94]
|
Larraufie, P., Martin-Gallausiaux, C., Lapaque, N., Dore, J., Gribble, F.M., Reimann, F. and Blottiere, H.M. (2018) SCFAs Strongly Stimulate PYY Production in Human Enteroendocrine Cells. Scientific Reports, 8, Article No. 74.
https://doi.org/10.1038/s41598-017-18259-0
|
[95]
|
Blaak, E.E., Canfora, E.E., Theis, S., Frost, G., Groen, A.K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., van Tol, R., Vaughan, E.E. and Verbeke, K. (2020) Short Chain Fatty Acids in Human Gut and Metabolic Health. Beneficial Microbes, 11, 411-455. https://doi.org/10.3920/BM2020.0057
|
[96]
|
Frost, G., Sleeth, M.L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., Anastasovska, J., Ghourab, S., Hankir, M., Zhang, S., Carling, D., Swann, J.R., Gibson, G., Viardot, A., Morrison, D., Louise Thomas, E. and Bell, J.D. (2014) The Short-Chain Fatty Acid Acetate Reduces Appetite via a Central Homeostatic Mechanism. Nature Communications, 5, Article No. 3611. https://doi.org/10.1038/ncomms4611
|
[97]
|
Davies, T.F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., Eckstein, A.K., Stagnaro-Green, A. and Kahaly, G.J. (2020) Graves’ Disease. Nature Reviews Disease Primers, 6, Article No. 52. https://doi.org/10.1038/s41572-020-0184-y
|
[98]
|
Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M., Glickman, J.N. and Garrett, W.S. (2013) The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis. Science, 341, 569-573.
https://doi.org/10.1126/science.1241165
|
[99]
|
Su, X., Yin, X., Liu, Y., Yan, X., Zhang, S., Wang, X., Lin, Z., Zhou, X., Gao, J., Wang, Z. and Zhang, Q. (2020) Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves’ Disease Patients by Propionic Acid. The Journal of Clinical Endocrinology & Metabolism, 105, 3526-3547.
https://doi.org/10.1210/clinem/dgaa511
|
[100]
|
Albillos, A., de Gottardi, A. and Rescigno, M. (2020) The Gut-Liver Axis in Liver Disease: Pathophysiological Basis for Therapy. Journal of Hepatology, 72, 558-577.
https://doi.org/10.1016/j.jhep.2019.10.003
|
[101]
|
Son, G., Kremer, M. and Hines, I.N. (2010) Contribution of Gut Bacteria to Liver Pathobiology. Gastroenterology Research and Practice, 2010, Article ID: 453563.
https://doi.org/10.1155/2010/453563
|
[102]
|
Zhou, D., Pan, Q., Xin, F.Z., Zhang, R.N., He, C.X., Chen, G.Y., Liu, C., Chen, Y.W. and Fan, J.G. (2017) Sodium Butyrate Attenuates High-Fat Diet-Induced Steatohepatitis in Mice by Improving Gut Microbiota and Gastrointestinal Barrier. World Journal of Gastroenterology, 23, 60-75. https://doi.org/10.3748/wjg.v23.i1.60
|
[103]
|
Ye, J., Lv, L., Wu, W., Li, Y., Shi, D., Fang, D., Guo, F., Jiang, H., Yan, R., Ye, W. and Li, L. (2018) Butyrate Protects Mice against Methionine-Choline-Deficient Diet-Induced Non-Alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels. Frontiers in Microbiology, 9, Article 1967. https://doi.org/10.3389/fmicb.2018.01967
|
[104]
|
Jin, C.J., Sellmann, C., Engstler, A.J., Ziegenhardt, D. and Bergheim, I. (2015) Supplementation of Sodium Butyrate Protects Mice from the Development of Non-Alcoholic Steatohepatitis (NASH). British Journal of Nutrition, 114, 1745-1755.
https://doi.org/10.1017/S0007114515003621
|
[105]
|
Rau, M., Rehman, A., Dittrich, M., Groen, A.K., Hermanns, H.M., Seyfried, F., Beyersdorf, N., Dandekar, T., Rosenstiel, P. and Geier, A. (2018) Fecal SCFAs and SCFA-Producing Bacteria in Gut Microbiome of Human NAFLD as a Putative Link to Systemic T-Cell Activation and Advanced Disease. United European Gastroenterology Journal, 6, 1496-1507. https://doi.org/10.1177/2050640618804444
|
[106]
|
Kelly, C.J., Zheng, L., Campbell, E.L., Saeedi, B., Scholz, C.C., Bayless, A.J., Wilson, K.E., Glover, L.E., Kominsky, D.J., Magnuson, A., Weir, T.L., Ehrentraut, S.F., Pickel, C., Kuhn, K.A., Lanis, J.M., Nguyen, V., Taylor, C.T. and Colgan, S.P. (2015) Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host & Microbe, 17, 662-671.
https://doi.org/10.1016/j.chom.2015.03.005
|
[107]
|
Demigné, C., Morand, C., Levrat, M.A., Besson, C., Moundras, C. and Rémésy, C. (1995) Effect of Propionate on Fatty Acid and Cholesterol Synthesis and on Acetate Metabolism in Isolated Rat Hepatocytes. British Journal of Nutrition, 74, 209-219.
https://doi.org/10.1079/BJN19950124
|
[108]
|
Deng, M., Qu, F., Chen, L., Liu, C., Zhang, M., Ren, F., Guo, H., Zhang, H., Ge, S., Wu, C. and Zhao, L. (2020) SCFAs Alleviated Steatosis and Inflammation in Mice with NASH Induced by MCD. Journal of Endocrinology, 245, 425-437.
https://doi.org/10.1530/JOE-20-0018
|
[109]
|
Canfora, E.E., van der Beek, C.M., Jocken, J.W.E., Goossens, G.H., Holst, J.J., Olde Damink, S.W.M., Lenaerts, K., Dejong, C.H.C. and Blaak, E.E. (2017) Colonic Infusions of Short-Chain Fatty Acid Mixtures Promote Energy Metabolism in Overweight/Obese Men: A Randomized Crossover Trial. Scientific Reports, 7, Article No. 2360. https://doi.org/10.1038/s41598-017-02546-x
|
[110]
|
Wang, Z., Zhang, X., Zhu, L., Yang, X., He, F., Wang, T., Bao, T., Lu, H., Wang, H. and Yang, S. (2020) Inulin Alleviates Inflammation of Alcoholic Liver Disease via SCFAs-Inducing Suppression of M1 and Facilitation of M2 Macrophages in Mice. International Immunopharmacology, 78, Article ID: 106062.
https://doi.org/10.1016/j.intimp.2019.106062
|
[111]
|
Grosicki, G.J., Fielding, R.A. and Lustgarten, M.S. (2018) Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis. Calcified Tissue International, 102, 433-442.
https://doi.org/10.1007/s00223-017-0345-5
|
[112]
|
Ticinesi, A., Lauretani, F., Milani, C., Nouvenne, A., Tana, C., Del Rio, D., Maggio, M., Ventura, M. and Meschi, T. (2017) Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut-Muscle Axis? Nutrients, 9, Article 1303. https://doi.org/10.3390/nu9121303
|
[113]
|
Lahiri, S., Kim, H., Garcia-Perez, I., Reza, M.M., Martin, K.A., Kundu, P., Cox, L.M., Selkrig, J., Posma, J.M., Zhang, H., Padmanabhan, P., Moret, C., Gulyás, B., Blaser, M.J., Auwerx, J., Holmes, E., Nicholson, J., Wahli, W. and Pettersson, S. (2019) The Gut Microbiota Influences Skeletal Muscle Mass and Function in Mice. Science Translational Medicine, 11. https://doi.org/10.1126/scitranslmed.aan5662
|
[114]
|
Nay, K., Jollet, M., Goustard, B., Baati, N., Vernus, B., Pontones, M., Lefeuvre-Orfila, L., Bendavid, C., Rué, O., Mariadassou, M., Bonnieu, A., Ollendorff, V., Lepage, P., Derbré, F. and Koechlin-Ramonatxo, C. (2019) Gut Bacteria Are Critical for Optimal Muscle Function: A Potential Link with Glucose Homeostasis. American Journal of Physiology-Endocrinology and Metabolism, 317, E158-e171.
https://doi.org/10.1152/ajpendo.00521.2018
|
[115]
|
Hsu, Y.J., Chiu, C.C., Li, Y.P., Huang, W.C., Huang, Y.T., Huang, C.C. and Chuang, H.L. (2015) Effect of Intestinal Microbiota on Exercise Performance in Mice. The Journal of Strength & Conditioning Research, 29, 552-558.
https://doi.org/10.1519/JSC.0000000000000644
|
[116]
|
Chen, Y.M., Wei, L., Chiu, Y.S., Hsu, Y.J., Tsai, T.Y., Wang, M.F. and Huang, C.C. (2016) Lactobacillus plantarum TWK10 Supplementation Improves Exercise Performance and Increases Muscle Mass in Mice. Nutrients, 8, Article 205.
https://doi.org/10.3390/nu8040205
|
[117]
|
Buigues, C., Fernández-Garrido, J., Pruimboom, L., Hoogland, A.J., Navarro-Martínez, R., Martínez-Martínez, M., Verdejo, Y., Mascarós, M.C., Peris, C. and Cauli, O. (2016) Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial. International Journal of Molecular Sciences, 17, Article 932. https://doi.org/10.3390/ijms17060932
|
[118]
|
Liu, L., Fu, C. and Li, F. (2019) Acetate Affects the Process of Lipid Metabolism in Rabbit Liver, Skeletal Muscle and Adipose Tissue. Animals (Basel), 9, Article 799.
https://doi.org/10.3390/ani9100799
|
[119]
|
Maruta, H., Yoshimura, Y., Araki, A., Kimoto, M., Takahashi, Y. and Yamashita, H. (2016) Activation of AMP-Activated Protein Kinase and Stimulation of Energy Metabolism by Acetic Acid in L6 Myotube Cells. PLOS ONE, 11, e0158055.
https://doi.org/10.1371/journal.pone.0158055
|
[120]
|
Han, J.H., Kim, I.S., Jung, S.H., Lee, S.G., Son, H.Y. and Myung, C.S. (2014) The Effects of Propionate and Valerate on Insulin Responsiveness for Glucose Uptake in 3T3-L1 Adipocytes and C2C12 Myotubes via G Protein-Coupled Receptor 41. PLOS ONE, 9, e95268. https://doi.org/10.1371/journal.pone.0095268
|
[121]
|
Fushimi, T., Tayama, K., Fukaya, M., Kitakoshi, K., Nakai, N., Tsukamoto, Y. and Sato, Y. (2001) Acetic Acid Feeding Enhances Glycogen Repletion in Liver and Skeletal Muscle of Rats. The Journal of Nutrition, 131, 1973-1977.
https://doi.org/10.1093/jn/131.7.1973
|
[122]
|
Kelley, G.A. and Kelley, K.S. (2017) Is Sarcopenia Associated with an Increased Risk of All-Cause Mortality and Functional Disability? Experimental Gerontology, 96, 100-103. https://doi.org/10.1016/j.exger.2017.06.008
|
[123]
|
Beaudart, C., Rizzoli, R., Bruyère, O., Reginster, J.Y. and Biver, E. (2014) Sarcopenia: Burden and Challenges for Public Health. Archives of Public Health, 72, Article No. 45. https://doi.org/10.1186/2049-3258-72-45
|
[124]
|
Beaudart, C., Dawson, A., Shaw, S.C., Harvey, N.C., Kanis, J.A., Binkley, N., Reginster, J.Y., Chapurlat, R., Chan, D.C., Bruyère, O., Rizzoli, R., Cooper, C. and Dennison, E.M. (2017) Nutrition and Physical Activity in the Prevention and Treatment of Sarcopenia: Systematic Review. Osteoporosis International, 28, 1817-1833.
https://doi.org/10.1007/s00198-017-3980-9
|
[125]
|
Ticinesi, A., Mancabelli, L., Tagliaferri, S., Nouvenne, A., Milani, C., Del Rio, D., Lauretani, F., Maggio, M.G., Ventura, M. and Meschi, T. (2020) The Gut-Muscle Axis in Older Subjects with Low Muscle Mass and Performance: A Proof of Concept Study Exploring Fecal Microbiota Composition and Function with Shotgun Metagenomics Sequencing. International Journal of Molecular Sciences, 21, Article 8946.
https://doi.org/10.3390/ijms21238946
|
[126]
|
Lv, W.Q., Lin, X., Shen, H., Liu, H.M., Qiu, X., Li, B.Y., Shen, W.D., Ge, C.L., Lv, F.Y., Shen, J., Xiao, H.M. and Deng, H.W. (2021) Human Gut Microbiome Impacts Skeletal Muscle Mass via Gut Microbial Synthesis of the Short-Chain Fatty Acid Butyrate among Healthy Menopausal Women. Journal of Cachexia, Sarcopenia and Muscle, 12, 1860-1870. https://doi.org/10.1002/jcsm.12788
|
[127]
|
Soares, A.D.N., Wanner, S.P., Morais, E.S.S., Hudson, A.S.R., Martins, F.S. and Cardoso, V.N. (2019) Supplementation with Saccharomyces boulardii Increases the Maximal Oxygen Consumption and Maximal Aerobic Speed Attained by Rats Subjected to an Incremental-Speed Exercise. Nutrients, 11, Article 2352.
https://doi.org/10.3390/nu11102352
|
[128]
|
Chen, L.H., Huang, S.Y., Huang, K.C., Hsu, C.C., Yang, K.C., Li, L.A., Chan, C.H. and Huang, H.Y. (2019) Lactobacillus paracasei PS23 Decelerated Age-Related Muscle Loss by Ensuring Mitochondrial Function in SAMP8 Mice. Aging (Albany NY), 11, 756-770. https://doi.org/10.18632/aging.101782
|
[129]
|
Walsh, M.E., Bhattacharya, A., Sataranatarajan, K., Qaisar, R., Sloane, L., Rahman, M.M., Kinter, M. and Van Remmen, H. (2015) The Histone Deacetylase Inhibitor Butyrate Improves Metabolism and Reduces Muscle Atrophy during Aging. Aging Cell, 14, 957-970. https://doi.org/10.1111/acel.12387
|
[130]
|
Okamoto, T., Morino, K., Ugi, S., Nakagawa, F., Lemecha, M., Ida, S., Ohashi, N., Sato, D., Fujita, Y. and Maegawa, H. (2019) Microbiome Potentiates Endurance Exercise through Intestinal Acetate Production. American Journal of Physiology-Endocrinology and Metabolism, 316, E956-e966.
https://doi.org/10.1152/ajpendo.00510.2018
|
[131]
|
Thadhani, R., Pascual, M. and Bonventre, J.V. (1996) Acute Renal Failure. The New England Journal of Medicine, 334, 1448-1460.
https://doi.org/10.1056/NEJM199605303342207
|
[132]
|
Mikami, D., Kobayashi, M., Uwada, J., Yazawa, T., Kamiyama, K., Nishimori, K., Nishikawa, Y., Nishikawa, S., Yokoi, S., Kimura, H., Kimura, I., Taniguchi, T. and Iwano, M. (2020) Short-Chain Fatty Acid Mitigates Adenine-Induced Chronic Kidney Disease via FFA2 and FFA3 Pathways. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, 1865, Article ID: 158666.
https://doi.org/10.1016/j.bbalip.2020.158666
|
[133]
|
Huang, W., Zhou, L., Guo, H., Xu, Y. and Xu, Y. (2017) The Role of Short-Chain Fatty Acids in Kidney Injury Induced by Gut-Derived Inflammatory Response. Metabolism, 68, 20-30. https://doi.org/10.1016/j.metabol.2016.11.006
|
[134]
|
Machado, R.A., Constantino Lde, S., Tomasi, C.D., Rojas, H.A., Vuolo, F.S., Vitto, M.F., Cesconetto, P.A., de Souza, C.T., Ritter, C. and Dal-Pizzol, F. (2012) Sodium Butyrate Decreases the Activation of NF-κB Reducing Inflammation and Oxidative Damage in the Kidney of Rats Subjected to Contrast-Induced Nephropathy. Nephrology Dialysis Transplantation, 27, 3136-3140. https://doi.org/10.1093/ndt/gfr807
|
[135]
|
Magliocca, G., Mone, P., Di Iorio, B.R., Heidland, A. and Marzocco, S. (2022) Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation. International Journal of Molecular Sciences, 23, Article 5354. https://doi.org/10.3390/ijms23105354
|
[136]
|
Gluba-Brzózka, A., Franczyk, B., Olszewski, R. and Rysz, J. (2020) The Influence of Inflammation on Anemia in CKD Patients. International Journal of Molecular Sciences, 21, Article 725. https://doi.org/10.3390/ijms21030725
|
[137]
|
Yilmaz, M.I., Solak, Y., Covic, A., Goldsmith, D. and Kanbay, M. (2011) Renal Anemia of Inflammation: The Name Is Self-Explanatory. Blood Purification, 32, 220-225.
https://doi.org/10.1159/000328037
|
[138]
|
Al Bander, Z., Nitert, M.D., Mousa, A. and Naderpoor, N. (2020) The Gut Microbiota and Inflammation: An Overview. International Journal of Environmental Research and Public Health, 17, Article 7618. https://doi.org/10.3390/ijerph17207618
|
[139]
|
Wu, H., Singer, J., Kwan, T.K., Loh, Y.W., Wang, C., Tan, J., Li, Y.J., Lai, S.W.C., Macia, L., Alexander, S.I. and Chadban, S.J. (2020) Gut Microbial Metabolites Induce Donor-Specific Tolerance of Kidney Allografts through Induction of T Regulatory Cells by Short-Chain Fatty Acids. Journal of the American Society of Nephrology, 31, 1445-1461. https://doi.org/10.1681/ASN.2019080852
|
[140]
|
Furue, K., Ito, T. and Furue, M. (2018) Differential Efficacy of Biologic Treatments Targeting the TNF-α/IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis. Cytokine, 111, 182-188. https://doi.org/10.1016/j.cyto.2018.08.025
|
[141]
|
Nussbaum, L., Chen, Y.L. and Ogg, G.S. (2021) Role of Regulatory T Cells in Psoriasis Pathogenesis and Treatment. British Journal of Dermatology, 184, 14-24.
https://doi.org/10.1111/bjd.19380
|
[142]
|
Kanda, N., Hoashi, T. and Saeki, H. (2021) The Defect in Regulatory T Cells in Psoriasis and Therapeutic Approaches. Journal of Clinical Medicine, 10, Article 3880.
https://doi.org/10.3390/jcm10173880
|
[143]
|
Luu, M. and Visekruna, A. (2019) Short-Chain Fatty Acids: Bacterial Messengers Modulating the Immunometabolism of T Cells. The European Journal of Immunology, 49, 842-848. https://doi.org/10.1002/eji.201848009
|
[144]
|
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J.R., Pfeffer, K., Coffer, P.J. and Rudensky, A.Y. (2013) Metabolites Produced by Commensal Bacteria Promote Peripheral Regulatory T-Cell Generation. Nature, 504, 451-455. https://doi.org/10.1038/nature12726
|
[145]
|
Schwarz, A., Philippsen, R. and Schwarz, T. (2021) Induction of Regulatory T Cells and Correction of Cytokine Disbalance by Short-Chain Fatty Acids: Implications for Psoriasis Therapy. Journal of Investigative Dermatology, 141, 95-104.e102.
https://doi.org/10.1016/j.jid.2020.04.031
|
[146]
|
Yao, Y., Cai, X., Fei, W., Ren, F., Wang, F., Luan, X., Chen, F. and Zheng, C. (2020) Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis during Pregnancy and Lactation. Frontiers in Pharmacology, 11, Article 594042.
https://doi.org/10.3389/fphar.2020.594042
|
[147]
|
Yao, Y., Cai, X., Zheng, Y., Zhang, M., Fei, W., Sun, D., Zhao, M., Ye, Y. and Zheng, C. (2022) Short-Chain Fatty Acids Regulate B Cells Differentiation via the FFA2 Receptor to Alleviate Rheumatoid Arthritis. British Journal of Pharmacology, 179, 4315-4329. https://doi.org/10.1111/bph.15852
|
[148]
|
Mirzaei, R., Afaghi, A., Babakhani, S., Sohrabi, M.R., Hosseini-Fard, S.R., Babolhavaeji, K., Khani Ali Akbari, S., Yousefimashouf, R. and Karampoor, S. (2021) Role of Microbiota-Derived Short-Chain Fatty Acids in Cancer Development and Prevention. Biomedicine & Pharmacotherapy, 139, Article ID: 111619.
https://doi.org/10.1016/j.biopha.2021.111619
|
[149]
|
Bodai, B.I. and Nakata, T.E. (2020) Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship. The Permanente Journal, 24, Article 129.
https://doi.org/10.7812/TPP/19.129
|
[150]
|
Walker, G.E., Wilson, E.M., Powell, D. and Oh, Y. (2001) Butyrate, a Histone Deacetylase Inhibitor, Activates the Human IGF Binding Protein-3 Promoter in Breast Cancer Cells: Molecular Mechanism Involves an Sp1/Sp3 Multiprotein Complex. Endocrinology, 142, 3817-3827. https://doi.org/10.1210/endo.142.9.8380
|
[151]
|
Bindels, L.B., Porporato, P., Dewulf, E.M., Verrax, J., Neyrinck, A.M., Martin, J.C., Scott, K.P., Buc Calderon, P., Feron, O., Muccioli, G.G., Sonveaux, P., Cani, P.D. and Delzenne, N.M. (2012) Gut Microbiota-Derived Propionate Reduces Cancer Cell Proliferation in the Liver. British Journal of Cancer, 107, 1337-1344.
https://doi.org/10.1038/bjc.2012.409
|
[152]
|
Maruyama, T., Yamamoto, S., Qiu, J., Ueda, Y., Suzuki, T., Nojima, M. and Shima, H. (2012) Apoptosis of Bladder Cancer by Sodium Butyrate and Cisplatin. Journal of Infection and Chemotherapy, 18, 288-295.
https://doi.org/10.1007/s10156-011-0322-2
|
[153]
|
Luu, M., Riester, Z., Baldrich, A., Reichardt, N., Yuille, S., Busetti, A., Klein, M., Wempe, A., Leister, H., Raifer, H., Picard, F., Muhammad, K., Ohl, K., Romero, R., Fischer, F., Bauer, C.A., Huber, M., Gress, T.M., Lauth, M., Danhof, S., Bopp, T., Nerreter, T., Mulder, I.E., Steinhoff, U., Hudecek, M. and Visekruna, A. (2021) Microbial Short-Chain Fatty Acids Modulate CD8+ T Cell Responses and Improve Adoptive Immunotherapy for Cancer. Nature Communications, 12, Article No. 4077. https://doi.org/10.1038/s41467-021-24331-1
|
[154]
|
Nomura, M., Nagatomo, R., Doi, K., Shimizu, J., Baba, K., Saito, T., Matsumoto, S., Inoue, K. and Muto, M. (2020) Association of Short-Chain Fatty Acids in the Gut Microbiome with Clinical Response to Treatment with Nivolumab or Pembrolizumab in Patients with Solid Cancer Tumors. JAMA Network Open, 3, e202895.
https://doi.org/10.1001/jamanetworkopen.2020.2895
|
[155]
|
Yang, F., Chen, H., Gao, Y., An, N., Li, X., Pan, X., Yang, X., Tian, L., Sun, J., Xiong, X. and Xing, Y. (2020) Gut Microbiota-Derived Short-Chain Fatty Acids and Hypertension: Mechanism and Treatment. Biomedicine & Pharmacotherapy, 130, Article ID: 110503. https://doi.org/10.1016/j.biopha.2020.110503
|